English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Lornoxicam (Lx) is a non-steroidal anti-inflammatory drug (NSAID) belonging to the oxicam class. This class of drugs is currently among the most commonly detected environmental pollutants, at concentrations ranging from the μg to ng L range, of great concern due to their potential effects and impacts on living organisms. In this context, this study aimed to develop an analytical methodology to quantify Lx in the water supply. The methodology comprises a pre-concentration step of the analyte through the application of solid phase extraction (SPE). In this step, an SPE cartridge containing the sorbent marketed under the name strata X was loaded with up to 2 L of an aqueous Lx solution, at a mass of 60 mg/3 mL, allowing for a 400-fold preconcentration factor. Quantification was carried out by adsorptive stripping voltammetry in the differential pulse mode. The conjugation of voltammetry with the SPE method led to a limit of detection 0.12 μg L and a limit of quantification of 0.40 μg L, with high selectivity, precision (<6.0 %), and accuracy (mean recovery of 97.60 ± 4.10 %, n = 6). No Lx was detected in the analyzed samples.

A Solid Phase Pre-Concentration Study Concerning Lornoxicam: A Likely Future Emerging Pollutant